Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.2100
+0.01638.42%
Pre-market: 0.21260.0026+1.24%05:42 EDT
Volume:258.46M
Turnover:62.90M
Market Cap:9.64M
PE:-0.10
High:0.2801
Open:0.2800
Low:0.2100
Close:0.1937
52wk High:1.50
52wk Low:0.1628
Shares:45.89M
Float Shares:45.14M
Volume Ratio:42.79
T/O Rate:572.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0797
EPS(LYR):-19.0286
ROE:-137.82%
ROA:-25.51%
PB:0.63
PE(LYR):-0.01

Loading ...

Theriva Biologics Inc - to Schedule End-of-Phase 2 Meeting With FDA in H1 2026

THOMSON REUTERS
·
Dec 29, 2025

Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement

Reuters
·
Dec 16, 2025

Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year

TIPRANKS
·
Nov 12, 2025

Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate

Benzinga
·
Nov 12, 2025

Theriva Biologics reports third quarter loss and lower R&D expenses

Reuters
·
Nov 12, 2025

Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Nov 01, 2025

Theriva Biologics: No Material Development to Account for Stock Activity

Dow Jones
·
Oct 25, 2025

Theriva Biologics sees no material development to account for unusual trading

TIPRANKS
·
Oct 25, 2025

Theriva Biologics Provides Response to Unusual Market Action

GlobeNewswire
·
Oct 25, 2025

Theriva Biologics Presents Promising Phase 2b Trial Data

TIPRANKS
·
Oct 21, 2025

Theriva Biologics Secures $4M Through Warrant Agreement

TIPRANKS
·
Oct 18, 2025

Theriva Biologics Raises $4 Million Through Warrant Inducement Private Placement

Reuters
·
Oct 18, 2025

Theriva Biologics announces warrant inducement transaction for $4M in proceeds

TIPRANKS
·
Oct 16, 2025

Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment

Reuters
·
Oct 06, 2025

Theriva Biologics Restructures, Cuts Workforce by 32%

TIPRANKS
·
Oct 03, 2025

BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC Filing

Reuters
·
Oct 03, 2025

Theriva Biologics Inc: Expects Will Extend Its Cash Runway Into Q2 of 2026

THOMSON REUTERS
·
Oct 03, 2025

Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities

Reuters
·
Oct 03, 2025